Since gracillin displays no obvious toxicity in normal cells derived from various organs and in mice [32], it is possible that gracillin may suppress specifically increased forms of PGK1, such as those modified posttranslationally or mutated, in cancer cells [65,66,67]. Here, PGK1 is linked to cancer.